|
|
 Previous Article | Table of Contents | Next Article 
Blood, 1 September 2000, Vol. 96, No. 5, pp. 1914-1920
NEOPLASIA
Acute myeloblastic leukemic cells acquire cellular cytotoxicity
under genotoxic stress: implication of granzyme B and
perforin
Alain Pierre Bruno,
Dominique Lautier,
Aurélie de Thonel d'Orgeix,
Guy Laurent, and
Anne Quillet-Mary
From Equipe Propre de l'Institut National de la
Santé et de la Recherche Médicale (INSERM) E9910, Institut
Claudius Régaud, Toulouse, France.
Granzyme B (GrB) and perforin (PFN) are the major components of
cytoplasmic granules contained in immune cellular effectors. The
granule secretory pathway is one of the mechanisms by which these cells
exert their cellular cytotoxicity. Recently, it has been reported that
GrB and PFN are also present in circulating hemopoietic
CD34+ progenitor cells mobilized by chemotherapy and
granulocyte-colony stimulating factor, whereas these proteins are
undetected in steady-state peripheral CD34+ cells. In this
study, we hypothesized that anticancer agents may increase GrB and PFN
expression in immature myeloid leukemic cells and that these treated
leukemic cells become cellular effectors through a granule-dependent
mechanism. Our results show that KG1a, HEL, and TF-1 CD34+
acute myeloblastic leukemia cells expressed both GrB and PFN. Moreover,
ionizing radiation, aracytine, and etoposide not only increase GrB and
PFN expression but also conferred potent cellular cytotoxicity to these
cells toward various cellular targets. Cellular cytotoxicity required
cell-cell contact, was not influenced by anti-tumor necrosis factor  or anti-Fas blocking antibodies, and was abrogated by GrB inhibitors or
antisense. These results suggest that, when exposed to genotoxic
agents, immature leukemic cells acquire potent GrB- and PFN-dependent
cellular cytotoxicity that can be potentially directed against
normal residual myeloid progenitors or immune effectors.
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati What's this?
This article has been cited by other articles:
|
|
|
|
 
T. Baba, S. Iwasaki, T. Maruoka, A. Suzuki, U. Tomaru, H. Ikeda, T. Yoshiki, M. Kasahara, and A. Ishizu
Rat CD4+CD8+ Macrophages Kill Tumor Cells through an NKG2D- and Granzyme/Perforin-Dependent Mechanism
J. Immunol.,
March 1, 2008;
180(5):
2999 - 3006.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
H. Hernandez-Pigeon, C. Jean, A. Charruyer, M.-J. Haure, C. Baudouin, M. Charveron, A. Quillet-Mary, and G. Laurent
UVA Induces Granzyme B in Human Keratinocytes through MIF: IMPLICATION IN EXTRACELLULAR MATRIX REMODELING
J. Biol. Chem.,
March 16, 2007;
282(11):
8157 - 8164.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
H. Hernandez-Pigeon, C. Jean, A. Charruyer, M.-J. Haure, M. Titeux, L. Tonasso, A. Quillet-Mary, C. Baudouin, M. Charveron, and G. Laurent
Human Keratinocytes Acquire Cellular Cytotoxicity under UV-B Irradiation: IMPLICATION OF GRANZYME B AND PERFORIN
J. Biol. Chem.,
May 12, 2006;
281(19):
13525 - 13532.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. B. Werner, S. W. G. Tait, E. de Vries, E. Eldering, and J. Borst
Requirement for Aspartate-cleaved Bid in Apoptosis Signaling by DNA-damaging Anti-cancer Regimens
J. Biol. Chem.,
July 2, 2004;
279(27):
28771 - 28780.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. J. Meech, L. McGavran, L. F. Odom, X. Liang, L. Meltesen, J. Gump, Q. Wei, S. Carlsen, and S. P. Hunger
Unusual childhood extramedullary hematologic malignancy with natural killer cell properties that contains tropomyosin 4-anaplastic lymphoma kinase gene fusion
Blood,
August 15, 2001;
98(4):
1209 - 1216.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
